Intra-tumor Injection of Drug-eluting Microspheres With Multiple Drugs
Recruiting
Phase 2
Interventional Study
Hepatocellular Carcinoma
Solid Tumor, Adult
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 99
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 100 (estimated)
- Sponsor
- Second Affiliated Hospital of Guangzhou Medical University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
To study the safety and clinical effect of injection of drug-eluting microspheres with multiple chemodrug and/or protein drugs into advanced solid tumors.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Solid advanced malignant tumors
* Age between18 and 99 years
* Life expectancy is greater than three months
Exclusion Criteria:
* Benign tumor
* Life expectancy is less than three months
* Serious medical comorbidity
* Others
Contacts